nejm tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity Tirzepatide for MASH with Liver

Common adverse effects include gastrointestinal symptoms such as nausea, vomiting, diarrhea, and constipation, which are generally mild to moderate and diminish over time

94%, p 5% after starting OP5 (84% of those where TIR was 10.0 mmol/L (49.3%(20.1) to 39.3%(15.3), p=0.006) and glucose management indicator (GMI) (7.97 (1.04) to 7.55 (0.77), p=0.011) improved significantly but change in HbA1c was not statistically significant (64.1 (16.2) to 60.7 (14.9), p=0.130, n=22)

No, semaglutide is not available over the counter

Doctors can adjust medications, run tests, and provide guidance to help reduce risks and keep the treatment safe and effective